Skip to main content
. 2024 Oct 9;10(21):e38806. doi: 10.1016/j.heliyon.2024.e38806

Table 1.

Overall patient demographics and preoperative characteristics.

No 3D 3D P value
No. of patients 177 147
Malesa 114 (64.4) 88 (59.9) 0.401
Ageb (yr) 58.1 (11.7) 58.6 (12.0) 0.654
BMIc (kg/m2) 25.7, 25.0 (23.5; 27.5) 25.1, 25.1 (23.2; 26.7) 0.227
ECOGc 0.21, 0 (0; 0) 0.24, 0 (0; 0) 0.889
ASA scorec 1.39, 1 (1; 2) 1.29, 1 (1; 2) 0.095
Preoperative hemoglobinc (g/L) 141.7, 143.0 (130.0; 156.0) 139.7, 141.0 (129.0; 151.0) 0.281
Tumor size at CT scanc (mm) 34.4, 32.0 (26.0; 41.0) 35.5, 33.0 (25.0; 43.0) 0.908
Clinical stagea 0.319
cT1a 130 (73.4) 104 (70.7)
cT1b 43 (24.3) 35 (23.8)
≥cT2 4 (2.3) 8 (5.4)
R.E.N.A.L. scorec 7.57, 8.0 (6.0; 9.0) 7.29, 7.0 (6.0; 8.0) 0.069
PADUA scorec 8.5, 8.0 (7.0; 9.0) 8.5, 8.0 (7.0; 10.0) 0.733
Tumor location (up/low)a 0.480
Upper pole 72 (40.7) 62 (42.2)
Mediorenal 49 (27.7) 47 (32.0)
Lower pole 56 (31.6) 38 (25.9)
Tumor location (anterior/posterior)a 0.549
Anterior 89 (50.3) 69 (46.9)
Posterior 88 (49.7) 78 (53.1)
Tumor location (rim)a 0.573
Medial rim 68 (38.4) 61 (41.5)
Lateral rim 109 (61.6) 86 (58.5)

ASA = American Society of Anesthesiologists; BMI = body mass index; CT = computed tomography; ECOG = Eastern Cooperative Oncology Group; IQR = interquartile range, a = no. (%); b = mean (standard deviation); c = mean, median (interquartile range).